| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.15 | 7e-05 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.14 | 9e-05 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.23 | 0.0001 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.23 | 0.0001 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.22 | 0.0003 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.0006 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0006 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.18 | 0.0007 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0008 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0008 |